
Tomocube is a South Korean company specializing in advanced 3D microscopic imaging technology called Holotomography, which enables non-invasive, label-free, high-resolution live-cell imaging. Their flagship product, the HT-X1 Plus, integrates holotomography with AI and multimodal imaging to facilitate live-cell 3D imaging for applications in regenerative medicine, disease modeling, and drug discovery. Tomocube also offers TomoAnalysis, a 3D image visualization and analysis software suite that uses AI for precise quantification and visualization of biological samples. The company has comprehensive in-house capabilities in hardware, software, optics, and AI development, allowing seamless integration and innovation. Tomocube is publicly listed on KOSDAQ and has a strong leadership team with deep scientific and industry expertise. Their technology is positioned as a game-changer in life sciences, enabling new insights in cell biology, immunology, 3D biology, and protein dynamics, supporting precision medicine and biomedical research globally.

Tomocube is a South Korean company specializing in advanced 3D microscopic imaging technology called Holotomography, which enables non-invasive, label-free, high-resolution live-cell imaging. Their flagship product, the HT-X1 Plus, integrates holotomography with AI and multimodal imaging to facilitate live-cell 3D imaging for applications in regenerative medicine, disease modeling, and drug discovery. Tomocube also offers TomoAnalysis, a 3D image visualization and analysis software suite that uses AI for precise quantification and visualization of biological samples. The company has comprehensive in-house capabilities in hardware, software, optics, and AI development, allowing seamless integration and innovation. Tomocube is publicly listed on KOSDAQ and has a strong leadership team with deep scientific and industry expertise. Their technology is positioned as a game-changer in life sciences, enabling new insights in cell biology, immunology, 3D biology, and protein dynamics, supporting precision medicine and biomedical research globally.